Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds.

Flow cytometry analysis of tumors revealed a significantly increased production of IFN-γ in the combination therapy group relative to anti–PD-1 alone, while the treatment of TAK-901 alone also showed an increasing trend (fig.

also in 63,971 other papers